NL255316A - - Google Patents

Info

Publication number
NL255316A
NL255316A NL255316DA NL255316A NL 255316 A NL255316 A NL 255316A NL 255316D A NL255316D A NL 255316DA NL 255316 A NL255316 A NL 255316A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL255316A publication Critical patent/NL255316A/xx
Priority claimed from CH7749159A external-priority patent/CH377824A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL255316D 1959-08-28 NL255316A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH7749159A CH377824A (de) 1959-08-28 1959-08-28 Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
CH29960 1960-01-13
CH210860 1960-02-25

Publications (1)

Publication Number Publication Date
NL255316A true NL255316A (cg-RX-API-DMAC7.html)

Family

ID=27171972

Family Applications (1)

Application Number Title Priority Date Filing Date
NL255316D NL255316A (cg-RX-API-DMAC7.html) 1959-08-28

Country Status (8)

Country Link
US (3) US3505314A (cg-RX-API-DMAC7.html)
BE (2) BE594436A (cg-RX-API-DMAC7.html)
DE (2) DE1192211B (cg-RX-API-DMAC7.html)
ES (5) ES260975A1 (cg-RX-API-DMAC7.html)
FR (1) FR772M (cg-RX-API-DMAC7.html)
GB (2) GB962462A (cg-RX-API-DMAC7.html)
MY (2) MY6700085A (cg-RX-API-DMAC7.html)
NL (1) NL255316A (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692906A (en) * 1970-06-24 1972-09-19 Colgate Palmolive Co Method of treating hypertension with morphanthridines
MX2009011360A (es) 2007-04-20 2010-02-12 Acucela Inc Compuestos derivados de estirenilo para tratar enfermedades y trastornos oftalmicos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3074931A (en) * 1963-01-22 Dibenzazepines
US2554736A (en) * 1951-05-29 Tertiary aminoalkyl-iminodibenzyls
DE1006421B (de) * 1952-01-25 1957-04-18 Geigy Ag J R Verfahren zur Herstellung von basischen Derivaten des Iminodibenzyls
AT200578B (de) * 1956-11-13 1958-11-10 Geigy Ag J R Verfahren zur Herstellung von neuen N-Aminoalkylderivaten von Azepinen

Also Published As

Publication number Publication date
FR772M (fr) 1961-08-11
BE594437A (fr) 1961-02-27
ES260976A1 (es) 1961-01-16
ES260975A1 (es) 1961-01-16
GB962461A (en) 1964-07-01
ES260974A1 (es) 1961-01-16
MY6700085A (en) 1967-12-31
BE594436A (fr) 1961-02-27
GB962462A (en) 1964-07-01
US3591691A (en) 1971-07-06
ES260978A1 (es) 1961-01-16
DE1182238B (de) 1964-11-26
MY6700079A (en) 1967-12-31
US3444159A (en) 1969-05-13
DE1192211B (de) 1965-05-06
ES260973A1 (es) 1961-01-16
US3505314A (en) 1970-04-07

Similar Documents

Publication Publication Date Title
AT219274B (cg-RX-API-DMAC7.html)
AT222246B (cg-RX-API-DMAC7.html)
AT219961B (cg-RX-API-DMAC7.html)
AT213627B (cg-RX-API-DMAC7.html)
AT213496B (cg-RX-API-DMAC7.html)
NL106615C (cg-RX-API-DMAC7.html)
NL123876C (cg-RX-API-DMAC7.html)
BE585093A (cg-RX-API-DMAC7.html)
BE586259A (cg-RX-API-DMAC7.html)
BE581586A (cg-RX-API-DMAC7.html)
NL247532A (cg-RX-API-DMAC7.html)
NL135271C (cg-RX-API-DMAC7.html)
BE586272A (cg-RX-API-DMAC7.html)
LU39161A1 (cg-RX-API-DMAC7.html)
BE577193A (cg-RX-API-DMAC7.html)
BE578868A (cg-RX-API-DMAC7.html)
BE582171A (cg-RX-API-DMAC7.html)
BE581706A (cg-RX-API-DMAC7.html)
NL249448A (cg-RX-API-DMAC7.html)
BE586017A (cg-RX-API-DMAC7.html)
BE586076A (cg-RX-API-DMAC7.html)
BE586035A (cg-RX-API-DMAC7.html)
BE567011A (cg-RX-API-DMAC7.html)
BE581509A (cg-RX-API-DMAC7.html)
BE585940A (cg-RX-API-DMAC7.html)